1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Institut de Recerca Biomèdica (IRB Barcelona)
  4. Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/192013
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMarin, Ines-
dc.contributor.authorSerrano Marugán, Manuel-
dc.contributor.authorPietrocola, Federico-
dc.date.accessioned2023-01-10T11:55:18Z-
dc.date.available2023-01-10T11:55:18Z-
dc.date.issued2022-12-15-
dc.identifier.issn2162-402X-
dc.identifier.urihttps://hdl.handle.net/2445/192013-
dc.description.abstractCancer therapy often induces senescence in some cancer cells. Senescent cells, due to their profoundly altered biology, may conceivably interact with the adaptive immune system in novel ways that may boost cancer immunosurveillance, triggering the clearance of both senescent and non-senescent neoplastic cells. In this regard, we have recently reported that senescent cancer cells exhibit potent antigenicity and adjuvanticity and can elicit strong CD8(+) T cell-dependent anticancer effects when used as vaccination agents.-
dc.format.extent3 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherTaylor & Francis-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1080/2162402X.2022.2154115-
dc.relation.ispartofOncoImmunology, 2023, vol. 12, num. 1, p. 2154115-
dc.relation.urihttps://doi.org/10.1080/2162402X.2022.2154115-
dc.rightscc by-nc (c) Marin, Ines et al., 2022-
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))-
dc.subject.classificationEnvelliment-
dc.subject.classificationInflamació-
dc.subject.classificationInterferó-
dc.subject.classificationVacunació-
dc.subject.otherAging-
dc.subject.otherInflammation-
dc.subject.otherInterferon-
dc.subject.otherVaccination-
dc.titleCellular senescence enhances adaptive anticancer immunosurveillance-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2023-01-09T12:33:44Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina6572486-
dc.identifier.pmid36531690-
Appears in Collections:Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))

Files in This Item:
File Description SizeFormat 
Marin_et_al_Oncoimmunology_2022.pdf481.92 kBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons